Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (371-380 of 942) with videos related to

Pageof 95
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
(S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitizationB A Morrow, E J Lee, J R Taylor, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapyJessica L Mega, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Shock (Augusta, Ga.)|April 10, 2023
CHANGES IN VASOACTIVE DRUG REQUIREMENTS AND MORTALITY IN CARDIAC INTENSIVE CARE UNIT PATIENTSJacob C Jentzer, Parag C Patel, Sean Van Diepen, et al.
European Heart Journal|March 19, 2008
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapyMichelle O'Donoghue, David A Morrow, Christopher P Cannon, et al.
American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.
Biochemistry|September 20, 2000
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domainJ A Morrow, M L Segall, S Lund-Katz, et al.
European Heart Journal|September 29, 2004
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarctionAmir Kashani, Robert P Giugliano, Elliott M Antman, et al.
Combinatorial Chemistry & High Throughput Screening|February 4, 2006
Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter functionLynda Allan, J Lianne Leith, Marianthi Papakosta, et al.
Biochemistry|July 13, 2006
The role of protein dynamics in increasing binding affinity for an engineered protein-protein interaction established by H/D exchange mass spectrometryJames R Horn, Brian Kraybill, Elizabeth J Petro, et al.
Pageof 95

Showing results (371-380 of 942) with videos related to

Sort By:
Pageof 95
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
(S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitizationB A Morrow, E J Lee, J R Taylor, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapyJessica L Mega, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Shock (Augusta, Ga.)|April 10, 2023
CHANGES IN VASOACTIVE DRUG REQUIREMENTS AND MORTALITY IN CARDIAC INTENSIVE CARE UNIT PATIENTSJacob C Jentzer, Parag C Patel, Sean Van Diepen, et al.
European Heart Journal|March 19, 2008
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapyMichelle O'Donoghue, David A Morrow, Christopher P Cannon, et al.
American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.
Biochemistry|September 20, 2000
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domainJ A Morrow, M L Segall, S Lund-Katz, et al.
European Heart Journal|September 29, 2004
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarctionAmir Kashani, Robert P Giugliano, Elliott M Antman, et al.
Combinatorial Chemistry & High Throughput Screening|February 4, 2006
Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter functionLynda Allan, J Lianne Leith, Marianthi Papakosta, et al.
Biochemistry|July 13, 2006
The role of protein dynamics in increasing binding affinity for an engineered protein-protein interaction established by H/D exchange mass spectrometryJames R Horn, Brian Kraybill, Elizabeth J Petro, et al.
Pageof 95